Justin Vaughan was appointed CEO of BrainZ in July 2003 and brings strong leadership and a broad range of skills to the organisation. Justin has a medical qualification from the University of Auckland and has significant previous experience in the global pharmaceutical industry, healthcare management, mergers and acquisitions, and management consultancy. Justin also had considerable achievement in the sporting arena having represented New Zealand in international cricket.

Christopher Williams, MSc (Hons), PhD
Chief Scientific Officer

Chris Williams is a world leading authority in brain injury and rescue research, and it is his research over 15 years that has led to the creation of BrainZ. He is an Associate Professor of the Liggins Institute at the University of Auckland, and has been the Head of the Neurosciences Group at the Research Centre for Developmental Medicine and Biology, (RCDMB) since 1992. He is also Head of the Discovery Team at NeuronZ.

Mr Smith is a director of several public and privately held companies including Fisher & Paykel Healthcare Corporation Ltd (Deputy Chairman), Auckland International Airport Ltd, Tru-Test Corporation Ltd, J B Were New Zealand Private Equity No. 1 Fund, United Networks Ltd and The Lion Foundation (Chairman).

Mr Smith held an Executive Director role with Lion Nathan from 1986 through until retirement in 2001.

Dr Robin Congreve, LL.M. (VUW), Ph.D.

Robin Congreve is Chairman of Tru-Test Limited and NeuronZ Limited and a principal of Oceania & Eastern Group, a New Zealand based private equity investment group. His directorships have included Comalco, Fay Richwhite, Freightways, Jardine Fleming and Lion Nathan Limited. He is also a past chairman of Post Office Bank, BNZ Finance, NZ Railways Corporation and past deputy chairman of the Bank of New Zealand Limited.

Des has been a Managing Director of Tru-Test Limited since 1987. He has a great deal of experience in international marketing. He has been a director of several public and privately held companies and institutions, including Industrial Research Limited, Salmond Smith Biolab Limited, Auckland Manufacturers' Association, Technology for Business Growth Committee of the Foundation for Research Science and Technology, and Chairman of New Zealand Agritech Inc. - an organisation which represents approximately $500 million in exports.

After practising law for 18 years and five years in investment banking, Mr. Boyd established a specialist advisory business and a career as a professional director. Mr. Boyd was appointed Chairman of Auckland International Airport Ltd in 1996 and is the Chairman of Allflex New Zealand Ltd, Allflex Australia Pty Ltd and the New Zealand Blood Service Ltd. He is also a director of Ngai Tahu Holdings Corporation Ltd, Ngai Tahu Fisheries Ltd, Izard Investments Ltd and Vulcan Steel Ltd. He is a member of the Institute of Directors. Mr. Boyd is also the chairman of the New Zealand Hockey Federation and the Bodmin Charitable Trust.

Mr Lawrie has worked in the technology sector for over 20 years, mostly in regional management positions for multinational companies and most recently as Managing Director of Microsoft New Zealand Ltd from 1996 to 2002. He is currently General Manager of Strategic Development for Microsoft in the Asia Pacific region. Mr Lawrie sits on the Advisory Board of the Knowledge Wave Trust and Competitive Auckland.

Professor Gluckman is one of New Zealand's most outstanding scientists, and was honoured by Queen Elizabeth II in 1997 with the Award of Companion of the New Zealand Order of Merit for his contributions to medical research. He was elected a Fellow of the Royal Society (London) in 2001, and was awarded the 2001 Rutherford Medal for Science and Technology by the Council of the Royal Society of New Zealand.

Professor Gluckman holds a Chair in Paediatrics and Perinatal Biology at the University of Auckland and was its Dean of Medicine until 2001. He is the Director of the Liggins Institute - a newly established research institute under the University of Auckland - and the Chief Scientific Officer of NeuronZ Limited.

Professor Joseph Volpe, MD
Department of Neurology, Children's Hospital and Harvard Medical School, Boston, USA

Professor J J Volpe is regarded as one of the world's most eminent paediatric neurologists, having developed a particular expertise in the area of neonatal brain disorders. He has published extensively contributing significantly to the field as it is taught today.

Since 1990 Professor Volpe has been the Neurologist-in-Chief at the Children's Hospital (Boston, Massachusetts, USA), the Chairman of the Department of Neurology (at the Children's Hospital and Harvard Medical School, Boston) and the Bronson Crothers' Professor of Neurology at Harvard Medical School.

Professor Paul Colditz, MBBS, FRACP, MBiomedE, FRCPCH, DPhil
Perinatal Research Centre, Royal Women's Hospital, Brisbane, Australia

Professor Paul Colditz is a Professor of Perinatal Medicine, University of Queensland, and Director of the Perinatal Research Centre at the Royal Women's Hospital, Brisbane, Australia.

Professor Colditz is a specialist paediatrician and neonatologist, who also holds a Masters degree in Biomedical Engineering and a Doctor of Philosophy degree from Oxford University, United Kingdom. He has done extensive and pioneering research in neonatal brain injury monitoring.

Associate Professor Terrie Inder, MD, FRACP, MBChB
Murdoch Children's Research Institute, Howard Florey Institute, Royal Women's and Royal Children's Hospital, Melbourne, Australia

Associate Professor Terrie Inder has served in a number of senior research roles at the University of Otago School of Medicine and the University of Auckland in New Zealand. She is also a Clinical Neurological Fellow at Harvard Medical School, Boston, USA.

In January 2001 she was appointed Associate Professor of Paediatrics at the University of Melbourne, and Clinical Neonatal Neurologist at the Royal Women's and the Royal Children's Hospital in Melbourne, Australia. Her research has focused on the problem of brain injury in premature babies.

Dr. Malcolm Battin, MBChB, MRCP (UK), FRCPCH, FRACP
Senior Lecturer in Neonatal Paediatrics, University of Auckland, and National Women's Hospital, Auckland, New Zealand

Senior Lecturer Malcolm Battin trained at the Royal Postgraduate Medical School, Hammersmith Hospital (London, United Kingdom), the British Columbia's Children's Hospital (Canada) and the Great Ormond Street Hospital (London, United Kingdom), among others. He has done pioneering work in the area of neonatal brain imaging.

Since arriving in New Zealand in July 1997, Malcolm has been a Senior Lecturer in Neonatal Paediatrics at the University of Auckland and the National Women's Hospital, Auckland.